Unnamed: 0,title,date,stock,sentiment
643927.0,Integra LifeSciences Announces Clinical Results For Integra Bilayer Wound Matrix,2020-05-15 08:10:00-04:00,IART,neutral
643928.0,"UBS Maintains Neutral on Integra Lifesciences, Lowers Price Target to $55",2020-05-08 14:11:00-04:00,IART,negative
643929.0,"Credit Suisse Maintains Outperform on Integra Lifesciences, Raises Price Target to $58",2020-05-08 10:28:00-04:00,IART,positive
643930.0,"JMP Securities Maintains Market Outperform on Integra Lifesciences, Lowers Price Target to $65",2020-05-08 08:47:00-04:00,IART,positive
643931.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,IART,negative
643932.0,"Integra Lifesciences Q1 Adj. EPS $0.480 Misses $0.640 Estimate, Sales $354.324M Miss $363.240M Estimate",2020-05-07 06:29:00-04:00,IART,negative
643933.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,IART,neutral
643934.0,Integra LifeSciences Sees Prelim. Q1 Sales $352M-$354M vs $367.38M Est.,2020-04-07 16:02:00-04:00,IART,neutral
643935.0,"Wells Fargo Maintains Equal-Weight on Integra Lifesciences, Lowers Price Target to $46",2020-04-06 09:33:00-04:00,IART,positive
643936.0,"Benzinga's Top Upgrades, Downgrades For April 3, 2020",2020-04-03 09:54:00-04:00,IART,positive
643937.0,"SunTrust Robinson Humphrey Initiates Coverage On Integra Lifesciences with Buy Rating, Announces Price Target to $55",2020-04-03 06:33:00-04:00,IART,neutral
643938.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,IART,negative
643939.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,IART,negative
643940.0,"The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment",2020-03-11 08:03:00-04:00,IART,positive
643941.0,Stocks That Hit 52-Week Lows On Tuesday,2020-03-10 10:37:00-04:00,IART,negative
643942.0,"Credit Suisse Maintains Outperform on Integra Lifesciences, Lowers Price Target to $65",2020-03-06 10:40:00-05:00,IART,positive
643943.0,"UBS Maintains Neutral on Integra Lifesciences, Raises Price Target to $65",2020-02-20 07:58:00-05:00,IART,neutral
643944.0,"The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche's Tecentriq sBLA",2020-02-19 07:21:00-05:00,IART,negative
643945.0,"Integra LifeSciences Sees FY20 Adj. EPS $3.00-$3.05 vs $3.00 Est., Sees Sales $1.55B-$1.57B vs $1.59B Est.",2020-02-19 06:04:00-05:00,IART,neutral
643946.0,"Integra Lifesciences Q4 EPS $0.68 Beats $0.67 Estimate, Sales $395.1M Miss $397.5M Estimate",2020-02-19 06:03:00-05:00,IART,negative
643947.0,"The Week Ahead In Biotech: Baudax Bio, Merck, Esperion Await FDA Decisions",2020-02-16 15:03:00-05:00,IART,positive
643948.0,"The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance",2020-01-15 08:22:00-05:00,IART,negative
643949.0,Integra Says Will Implement $225M Buyback Plan Previously Approved By Board,2020-01-14 16:07:00-05:00,IART,positive
643950.0,Integra Sees FY20 Sales $1.55B-$1.57B vs $1.6B Estimate,2020-01-14 16:06:00-05:00,IART,neutral
643951.0,Integra LifeSciences Sees Q4 Sales At Or Near Low End Of $395M-$400M Range vs $397.9M Estimate,2020-01-14 16:06:00-05:00,IART,negative
643952.0,"Benzinga's Top Upgrades, Downgrades For January 7, 2020",2020-01-07 11:17:00-05:00,IART,positive
643953.0,"Piper Sandler Downgrades Integra Lifesciences to Neutral, Lowers Price Target to $58",2020-01-07 07:53:00-05:00,IART,negative
643954.0,"Benzinga's Top Upgrades, Downgrades For January 3, 2020",2020-01-03 11:33:00-05:00,IART,positive
643955.0,"UBS Maintains Neutral on Integra Lifesciences, Raises Price Target to $65",2019-12-18 08:18:00-05:00,IART,neutral
643956.0,Integra Lifesciences shares are trading lower after the company narrowed its FY19 sales guidance to the lower end of analyst estimates.,2019-10-24 14:19:00-04:00,IART,negative
643957.0,"The Daily Biotech Pulse: Acorda To Trim Jobs, GlaxoSmithKline Gets FDA Nod, Edward Lifesciences Posts Q3 Beat-And-Raise",2019-10-24 07:36:00-04:00,IART,neutral
643958.0,Integra Reaffirms FY19 Adj. EPS Guidance $2.70-$2.75,2019-10-24 06:14:00-04:00,IART,neutral
643959.0,"Integra Lifesciences Q3 Adj. EPS $0.68 Beats $0.65 Estimate, Sales $379.095M Beat $376.69M Estimate",2019-10-24 06:14:00-04:00,IART,neutral
643960.0,"The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict",2019-10-20 08:08:00-04:00,IART,positive
643961.0,"Wells Fargo Maintains Market Perform on Integra Lifesciences, Lowers Price Target to $65",2019-10-08 08:21:00-04:00,IART,positive
643962.0,Integra LifeSciences Holdings Corporation Announced Positive Findings From Its CadenceÂ® Total Ankle System Retrospective Study,2019-09-18 16:19:00-04:00,IART,positive
643963.0,"Integra LifeSciences Acquires Rebound Therapeutics, Terms Not Disclosed",2019-09-09 07:42:00-04:00,IART,neutral
643964.0,"Integra LifeSciences Reports Purchase Of Arkis Biosciences, No Terms Disclosed",2019-07-29 16:24:00-04:00,IART,negative
643965.0,50 Biggest Movers From Yesterday,2019-07-25 05:50:00-04:00,IART,neutral
643966.0,38 Stocks Moving In Wednesday's Mid-Day Session,2019-07-24 13:57:00-04:00,IART,neutral
643967.0,Integra Lifesciences shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. The company also raised FY19 EPS guidance.,2019-07-24 11:24:00-04:00,IART,positive
643968.0,Integra LifeSciences Raised FY19 EPS Guidance From $2.65-$2.72 To $2.70-$2.75 vs $2.70 Estimate,2019-07-24 10:06:00-04:00,IART,neutral
643969.0,"Integra Lifesciences Earlier Reported Q2 Adj. EPS $0.73 Beat $0.66 Estimate, Sales $383.645M Beat $373.29M Estimate",2019-07-24 10:04:00-04:00,IART,neutral
643970.0,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",2019-07-24 07:08:00-04:00,IART,neutral
643971.0,The Week Ahead In Biotech: Pharma Earnings Pick Up Pace,2019-07-20 09:53:00-04:00,IART,neutral
643972.0,"The Daily Biotech Pulse: FDA Greenlights AbbVie's Psoriasis Drug, Novartis Earnings, Patent Notification For MediciNova",2019-04-24 08:09:00-04:00,IART,neutral
643973.0,Integra Lifesciences Reaffirms FY19 Guidance,2019-04-24 06:12:00-04:00,IART,neutral
643974.0,"Integra Lifesciences Q1 Adj. EPS $0.65 Beats $0.61 Estimate, Sales $359.7M Miss $360.38M Estimate",2019-04-24 06:12:00-04:00,IART,negative
643975.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,IART,positive
643976.0,"The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs",2019-04-21 14:06:00-04:00,IART,neutral
643977.0,Shares of several medical device companies are trading lower with the healthcare sector. Healthcare has seen weakness recently due to concerns over the future of the Affordable Act under Trump and healthcare policy uncertainty ahead of the 2020 election.,2019-04-17 12:45:00-04:00,IART,negative
643978.0,Integra LifeSciences Reports Approval Of DuraGen In Japan,2019-03-14 08:15:00-04:00,IART,positive
643979.0,65 Biggest Movers From Yesterday,2019-02-22 05:02:00-05:00,IART,neutral
643980.0,50 Stocks Moving In Thursday's Mid-Day Session,2019-02-21 13:24:00-05:00,IART,neutral
643981.0,"The Daily Biotech Pulse: Genomic Health Earnings, AbbVie's Humira Approved For Another Indication In Japan",2019-02-21 07:32:00-05:00,IART,positive
643982.0,Integra LifeSciences Sees FY19 Sales $1.515B-$1.525B vs $1.53B Estimate,2019-02-21 06:16:00-05:00,IART,neutral
643983.0,"Integra Lifesciences Hold Q4 EPS $0.65 Beats $0.62 Estimate, Sales $383.315M Beat $381.62M Estimate",2019-02-21 06:16:00-05:00,IART,neutral
643984.0,Integra LifeSciences Sees Q4 Sales At Higher End Of $378M-$383M Range vs $380M Est.,2019-01-08 07:01:00-05:00,IART,neutral
643985.0,"Benzinga's Top Upgrades, Downgrades For January 3, 2019",2019-01-03 09:09:00-05:00,IART,positive
643986.0,"SunTrust Robinson Humphrey Initiates Coverage On Integra Lifesciences with Buy Rating, Announces $56 Price Target",2019-01-03 08:08:00-05:00,IART,neutral
643987.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,IART,neutral
643988.0,"Credit Suisse Initiates Coverage On Integra Lifesciences with Outperform Rating, Announces $57 Price Target",2018-12-18 07:31:00-05:00,IART,positive
643989.0,Integra Lifesciences 8-K Shows $225M Buyback,2018-12-12 11:17:00-05:00,IART,neutral
643990.0,"UBS Initiates Coverage On Integra Lifesciences with Neutral Rating, Announces $58 Price Target",2018-11-28 08:05:00-05:00,IART,neutral
643991.0,82 Biggest Movers From Yesterday,2018-11-01 04:38:00-04:00,IART,neutral
643992.0,66 Stocks Moving In Wednesday's Mid-Day Session,2018-10-31 12:50:00-04:00,IART,neutral
643993.0,"The Daily Biotech Pulse: KemPharm, FDA Nod For Merck, Clovis Q3 Miss, 3 Stocks To Debut",2018-10-31 08:20:00-04:00,IART,negative
643994.0,"Integra LifeSciences Holdings Corporation Sees FY18 Adj. EPS $2.36-$2.42 vs $2.40 Est., Sales $1.467B-$1.472B vs $1.49B Est.",2018-10-31 06:22:00-04:00,IART,neutral
643995.0,"Integra LifeSciences Holdings Corporation Q3 Adj. EPS $0.59, Inline, Sales $365.9M Miss $370.41M Estimate",2018-10-31 06:20:00-04:00,IART,negative
643996.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs",2018-10-27 10:23:00-04:00,IART,neutral
643997.0,Integra LifeSciences Selected For Healogics iSupply Program,2018-09-10 16:03:00-04:00,IART,neutral
643998.0,Bank of America Downgrades Integra Lifesciences to Underperform,2018-08-07 09:34:00-04:00,IART,neutral
643999.0,"Benzinga's Top Upgrades, Downgrades For July 26, 2018",2018-07-26 08:58:00-04:00,IART,positive
644000.0,BTIG Research Upgrades Integra Lifesciences to Buy,2018-07-26 07:49:00-04:00,IART,neutral
644001.0,"Benzinga's Daily Biotech Pulse: Merck's Keytruda Found Effective, Nabriva To Acquire Zavante, FDA Denies Agile",2018-07-25 08:41:00-04:00,IART,positive
644002.0,"Integra LifeSciences Raises FY18 From $1.47-$1.49B To $1.475-$1.49B, EPS Raised From $2.34-$2.42 To $2.36-$2.42",2018-07-25 06:10:00-04:00,IART,neutral
644003.0,Integra LifeSciences Raises Low-End of Full-Year Total Revenue and EPS Guidance,2018-07-25 06:09:00-04:00,IART,neutral
644004.0,"Integra Lifesciences Q2 EPS $0.60, Inline, Sales $366.19M Miss $368.31M Estimate",2018-07-25 06:08:00-04:00,IART,negative
644005.0,"Benzinga's Top Upgrades, Downgrades For July 2, 2018",2018-07-02 09:21:00-04:00,IART,positive
644006.0,"Citigroup Downgrades Integra Lifesciences to Neutral, Raises Price Target to $66",2018-07-02 08:09:00-04:00,IART,neutral
644007.0,"Benzinga's Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid Addiction Drug",2018-06-15 09:13:00-04:00,IART,neutral
644008.0,"Benzinga's Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer's Trial Results",2018-05-10 09:44:00-04:00,IART,neutral
644009.0,Integra LifeSciences Late Wednesday Priced 5.25M Share Offering At $58.50/Share,2018-05-10 08:59:00-04:00,IART,positive
644010.0,32 Stocks Moving In Thursday's Pre-Market Session,2018-05-10 08:08:00-04:00,IART,neutral
644011.0,Integra LifeSciences Prices 5.25M Share Public Offering of Common Stock @$58.50/Share,2018-05-10 03:57:00-04:00,IART,positive
644012.0,Integra LifeSciences Announces 5.25M Share Common Stock Offering,2018-05-09 16:14:00-04:00,IART,positive
644013.0,"Benzinga's Daily Biotech Pulse: Portola Receives FDA Nod, Mallinckrodt Gets Thumbs Down",2018-05-04 08:16:00-04:00,IART,neutral
644014.0,"Benzinga's Daily Biotech Pulse: Intra-cellular Moves On Poster Presentation, Earnings Beats From Vertex, Exact Sciences",2018-04-27 07:25:00-04:00,IART,neutral
644015.0,"Benzinga's Daily Biotech Pulse: Catabasis Soars On Trial Results, Eloxx Listing, Biomarin Earnings",2018-04-26 08:07:00-04:00,IART,neutral
644016.0,"Benzinga's Biotech Pulse: Takeda Sweetens Shire Offer Again, Menlo's Woes Abound, Earnings Fail to Boost Amgen",2018-04-25 07:46:00-04:00,IART,negative
644017.0,"Integra LifeSciences Raises Adj. EPS From $2.25-$2.35 To $2.34-$2.42, Sales From $1.46-$1.48B To $1.47-$1.49B",2018-04-25 06:04:00-04:00,IART,neutral
644018.0,Integra LifeSciences Raises FY18 Guidance,2018-04-25 06:03:00-04:00,IART,neutral
644019.0,"Integra LifeSciences Q1 Adj. EPS $0.58 Beats $0.49 Est., Sales $357.1M Beats $349.1M Est.",2018-04-25 06:03:00-04:00,IART,neutral
644020.0,"The Week Ahead In Biotech: PDUFA Dates, IPOs And More",2018-04-20 14:00:00-04:00,IART,neutral
644021.0,"Benzinga's Top Upgrades, Downgrades For April 5, 2018",2018-04-05 09:23:00-04:00,IART,positive
644022.0,"BTIG Research Initiates Coverage On Integra Lifesciences with Neutral Rating, Announces $56.00 Price Target",2018-04-05 06:58:00-04:00,IART,neutral
644023.0,"Integra LifeSciences Sees FY18 Sales $1.46-$1.48B vs $1.47B Est., EPS 2.25-$2.35 vs $2.30 Est.",2018-02-27 06:04:00-05:00,IART,neutral
644024.0,"Integra LifeSciences Reports Q4 EPS $0.64 vs $0.56 Est., Sales $368.6M vs $356M Est.",2018-02-27 06:04:00-05:00,IART,neutral
644025.0,"Integra LifeSciences Reports Prelim Q4 Sales ~$365M vs Previous Guidance Of $345-$355M, Sees EPS $0.53-$0.57",2018-01-08 06:31:00-05:00,IART,neutral
644026.0,"Raymond James Downgrades Integra LifeSciences As They See Fewer Catalysts To Drive Investor Sentiment In First Half Of 2018, Sees Co. As A Better Story In The Second Half Of 2018",2018-01-02 10:17:00-05:00,IART,positive
644027.0,Raymond James Downgrades Integra Lifesciences to Market Perform,2018-01-02 10:14:00-05:00,IART,neutral
644028.0,Bank of America Downgrades Integra Lifesciences to Neutral,2018-01-02 09:02:00-05:00,IART,neutral
644029.0,Oppenheimer Serves Up 29 Top Stock Ideas For January,2017-12-19 17:43:00-05:00,IART,positive
644030.0,Wells Fargo Downgrades Integra Lifesciences to Market Perform,2017-10-30 07:23:00-04:00,IART,positive
644031.0,JP Morgan Downgrades Integra Lifesciences to Neutral,2017-10-27 07:21:00-04:00,IART,positive
644032.0,40 Biggest Movers From Yesterday,2017-10-27 04:57:00-04:00,IART,neutral
644033.0,35 Stocks Moving In Thursday's Mid-Day Session,2017-10-26 12:44:00-04:00,IART,neutral
644034.0,30 Stocks Moving In Thursday's Pre-Market Session,2017-10-26 08:06:00-04:00,IART,neutral
644035.0,"Integra LifeSciences Reports Q3 EPS $0.45 vs $0.47 Est., Sales $278.8M vs $286M Est.",2017-10-26 06:07:00-04:00,IART,neutral
644036.0,Integra LifeSciences Launches Revize/ Revize-X Collagen Matrix,2017-10-06 08:31:00-04:00,IART,neutral
644037.0,Integra LifeSciences Launches SurgiMend,2017-10-03 16:15:00-04:00,IART,neutral
644038.0,FTC Says It Requires Divestiture Of 5 Medical Device Product Lines As Condition Of Integra Acquiring Johnson & Johnson's Codman Neuro Division,2017-09-27 11:08:00-04:00,IART,neutral
644039.0,Integra LifeSciences Says its Puerto Rico Manufacturing Facility Suffered Minor Damage from Hurricane Maria,2017-09-26 08:08:00-04:00,IART,negative
644040.0,Integra LifeSciences Announces 1st Patient Enrolled In Cadenct Totla Ankle System Post-Market Study,2017-09-21 17:00:00-04:00,IART,neutral
644041.0,"Wall Street's M&A Chatter From September 11: Western Digital-Toshiba, Pilgrim's Pride-Moy Park, Gigamon And More",2017-09-12 07:52:00-04:00,IART,neutral
644042.0,A Peek Into The Markets: U.S. Stock Futures Signal Higher Start On Wall Street,2017-09-11 07:54:00-04:00,IART,neutral
644043.0,UPDATE: Integra Says Sees Codman Neurosurgery Contributing $290M-$300M In Sales During FY18,2017-09-11 07:35:00-04:00,IART,neutral
644044.0,UPDATE: Integra LifeSciences Expects Q4 Sales Contribution Of $60M-$65M Related To Planned Acquisition Of Codman Neurosurgery,2017-09-11 07:34:00-04:00,IART,neutral
644045.0,Natus Medical Reports Purchase Of Neurosurgery Assets From Integra LifeSciences For $47.5M,2017-09-11 07:31:00-04:00,IART,positive
644046.0,Oppenheimer Presents New Menu Of Top Picks,2017-09-01 11:59:00-04:00,IART,positive
644047.0,18 Biggest Mid-Day Losers For Wednesday,2017-07-26 13:04:00-04:00,IART,negative
644048.0,"Integra LifeSciences Tightens FY 2017 Sales Guidance, Reaffirms EPS Guidance",2017-07-26 06:19:00-04:00,IART,neutral
644049.0,"Integra LifeSciences Q2 EPS $0.45 vs $0.45 Est., Sales $282.2M vs $283.7M Est.",2017-07-26 06:18:00-04:00,IART,neutral
644050.0,"Cantor Fitzgerald Initiates Coverage On Integra Lifesciences with Overweight Rating, Announces $65.00 Price Target",2017-06-30 06:29:00-04:00,IART,negative
644051.0,Oppenheimer Analysts Release 28 Best Ideas List,2017-06-29 13:24:00-04:00,IART,positive
644052.0,Integra LifeSciences Reports Agreement with aap to Distribute LOQTEQ In U.S.,2017-05-23 08:06:00-04:00,IART,positive
644053.0,Integra LifeSciences launches SurgiMend MP Collagen Matrix for Hernia Repair,2017-05-12 08:02:00-04:00,IART,neutral
644054.0,Integra LifeSciences Reaffirms FY 2017 Guidance,2017-04-26 06:13:00-04:00,IART,neutral
644055.0,"Integra LifeSciences Q1 EPS $0.39 vs $0.40 Est, Sales $258.6M vs $254.2M Est",2017-04-26 06:12:00-04:00,IART,neutral
644056.0,Integra LifeSciences Increases Credit Facility from $1.5B to $2.2B,2017-04-04 16:09:00-04:00,IART,positive
644057.0,Integra LifeSciences Reports Acceptance of Shares Tendered Into Offer for Derma Sciences,2017-02-23 08:35:00-05:00,IART,positive
644058.0,"Integra LifeSciences Sees FY17 Sales $1.12-$1.14B vs. $1.1B Est, Adj. EPS $1.88-$1.94 vs. $1.93 Est.",2017-02-23 07:08:00-05:00,IART,neutral
644059.0,"Integra LifeSciences Reports Q4 Adj. EPS $0.52 vs. Inline, Sales $255.7M vs. $257.2M",2017-02-23 07:07:00-05:00,IART,neutral
644060.0,"A Peek Into The Markets: U.S. Stock Futures Mostly Higher Ahead Of Economic Data, Yellen Speech",2017-02-15 07:44:00-05:00,IART,neutral
644061.0,Integra Acquires Codman Neurosurgery Business From Johnson & Johnson for $1.045B Cash,2017-02-15 07:02:00-05:00,IART,neutral
644062.0,Mid-Afternoon Market Update: Derma Sciences Climbs On Acquisition News; Novadaq Shares Plunge,2017-01-11 14:31:00-05:00,IART,positive
644063.0,15 Biggest Mid-Day Gainers For Wednesday,2017-01-11 12:35:00-05:00,IART,neutral
644064.0,Mid-Day Market Update: Crude Oil Up 2.5%; Ethan Allen Shares Drop On Weak Forecast,2017-01-11 12:01:00-05:00,IART,negative
644065.0,Mid-Morning Market Update: Markets Mostly Higher; SUPERVALU Earnings Miss Views,2017-01-11 09:54:00-05:00,IART,negative
644066.0,22 Stocks Moving In Wednesday's Pre-Market Session,2017-01-11 08:22:00-05:00,IART,neutral
644067.0,Integra Lifesciences to Acquire Derma Sciences for $7.00/Share in Cash,2017-01-11 04:33:00-05:00,IART,neutral
644068.0,JMP Securities Upgrades Integra Lifesciences to Market Outperform,2017-01-06 06:23:00-05:00,IART,positive
644069.0,Integra LifeSciences Aprroves 2-For-1 Stock Split,2016-12-22 08:02:00-05:00,IART,neutral
644070.0,Watch These 5 Huge Call Purchases In Wednesday Trade,2016-12-14 04:10:00-05:00,IART,positive
644071.0,Option Alert: IART Jan17 90.0 Calls: 1000 @  ASK  $0.80: 1000 traded vs 0 OI:  Earnings 2/23 After Close (est)  $82.19 Ref,2016-12-13 10:44:00-05:00,IART,positive
644072.0,Benzinga's Top Initiations,2016-12-12 09:49:00-05:00,IART,positive
644073.0,"UBS Initiates Coverage On Integra Lifesciences at Buy, Announces $96.00 Target",2016-12-12 07:10:00-05:00,IART,neutral
644074.0,Glenn Coleman Announces Integra LifeSciences CFO,2016-12-05 08:31:00-05:00,IART,neutral
644075.0,Lake Street Upgrades Integra LifeSciences Holdings Corporation - Common Stock to Buy,2016-10-28 09:07:00-04:00,IART,neutral
644076.0,"Integra LifeSciences Sees FY16 Rev. $992M-$1B vs. Est. $999M, EPS $3.47-$3.53 vs. Est. $3.48",2016-10-27 17:06:00-04:00,IART,neutral
644077.0,"Integra LifeSciences Reports Q3 EPS $0.93 vs. Est. $0.89, Rev. $250.3M vs. Est. $249.3M",2016-10-27 17:06:00-04:00,IART,neutral
644078.0,Integra LifeSciences Announces Plans for a Two-For-One Stock Split,2016-10-27 16:41:00-04:00,IART,neutral
644079.0,Strong Top And Bottom Line Growth Expected From Integra,2016-09-23 10:22:00-04:00,IART,positive
644080.0,"Integra Lifesciences Reports Q2 Adj. EPS $0.79 vs $0.75 in Same Qtr. Last Year, Sales $249.3M",2016-07-28 06:22:00-04:00,IART,neutral
644081.0,JP Morgan Initiates Coverage on Integra Lifesciences at Overweight,2016-07-13 09:11:00-04:00,IART,neutral
644082.0,Integra LifeSciences Receives FDA Approval for Integra Omnigraft Dermal Regeneration Matrix,2016-05-11 08:32:00-04:00,IART,positive
644083.0,"Integra LifeSciences Raises Guidance; Sees FY 2016 EPS $3.38 to $3.50 vs $3.43 est, Revenue $985M to $1000M vs $987M est",2016-04-27 06:09:00-04:00,IART,neutral
644084.0,"Integra LifeSciences Q1 EPS $0.74 vs $0.73 est, Revenue $236.8M vs $230.7M est",2016-04-27 06:08:00-04:00,IART,neutral
644085.0,Integra Reports Deal with AlloSource to Commercialize HuMend,2016-04-26 16:28:00-04:00,IART,neutral
644086.0,Integra LifeSciences Reports Deal with Vomaris Wound Care to Commercialize VolTAC Antimicrobial Wound Dressing,2016-04-14 08:32:00-04:00,IART,positive
644087.0,"Integra LifeSciences Reports Won $10.3M DoD Contract for Providing Greater Access to Both Specialty Surgical Soltuions, Orthopedics & Tissue Technology Products",2016-03-10 08:32:00-05:00,IART,positive
644088.0,"Integra Lifesciences Sees FY16 Organic Growth of ~7%, Adj. EPS Growth in Double Digit Range",2016-02-25 16:40:00-05:00,IART,positive
644089.0,"Integra Lifesciences Reports Q4 Adj. EPS $0.87 vs $0.86 Est., Sales $241.2M vs $241.1M Est.",2016-02-25 16:40:00-05:00,IART,neutral
644090.0,Integra LifeSciences Release Confirms Company Given FDA Approval of Integra Dermal Regeneration Template (IDRT) for Treatment of Chronic Diabetic Foot Ulcers (DFU),2016-01-07 14:22:00-05:00,IART,positive
644091.0,Hearing FDA Has Approve Integra's Omnigraft Dermal Regeneration Matrix for Treatment of Diabetic Foot Pain,2016-01-07 12:44:00-05:00,IART,negative
644092.0,"Citigroup Initiates Coverage on Integra Lifesciences at Buy, Announces $75.00 PT",2015-11-12 06:34:00-05:00,IART,neutral
644093.0,Integra Lifesciences Sees FY EPS $3.05 to $3.10 vs $3.06 est,2015-11-03 06:05:00-05:00,IART,neutral
644094.0,"Integra Lifesciences Q3 EPS $0.75 vs $0.74 est, Revenue $226.4M vs $224.1M est",2015-11-03 06:05:00-05:00,IART,neutral
644095.0,Integra LifeSciences Announces Received Expanded Indication for CUSA Excel System for Liver Surgery,2015-10-30 08:32:00-04:00,IART,positive
644096.0,"Integra LifeSciences Files Patent Infringement Lawsuit Against HyperBranch Medical Technology, Inc.",2015-09-15 16:15:00-04:00,IART,negative
644097.0,Integra LifeSciences to Acquire Total Ankle Replacement and Silastic Toe Replacement Product Portfolios from Tornier N.V.; Amount of Cash Payment Not Disclosed,2015-09-03 05:43:00-04:00,IART,neutral
644098.0,Integra LifeSciences Increases Credit Facility From $900M To $1.1B,2015-09-01 16:16:00-04:00,IART,positive
644099.0,Integra LifeSciences Reports FOUNDER Study Results Which Show Increased Rate of Complete Wound Closure and Decreased Time to Complete Wound Closure With Integra Dermal Regeneration Template for Treatment of Chronic Diabetic Foot Ulcers,2015-08-25 16:16:00-04:00,IART,positive
644100.0,Integra LifeSciences Reports $200M Stock Offering,2015-08-03 16:25:00-04:00,IART,neutral
644101.0,JP Morgan Upgrades Integra Lifesciences to Overweight,2015-07-31 09:32:00-04:00,IART,neutral
644102.0,"Integra LifeScience Holdings Corp Reports Q2 Adj EPS $0.79 vs Est $0.72, Revs $244.1M Vs Est $210.08M",2015-07-30 06:13:00-04:00,IART,neutral
644103.0,Raymond James Upgrades Integra Lifesciences to Outperform,2015-07-29 07:52:00-04:00,IART,neutral
644104.0,Mid-Morning Market Update: Markets Edge Higher; Centene To Acquire Health Net For $6.3B,2015-07-02 11:05:00-04:00,IART,neutral
644105.0,"Must Watch Stocks for June 29, 2015",2015-06-29 05:53:00-04:00,IART,neutral
644106.0,Benzinga's Weekend M&A Chatter,2015-06-28 20:20:00-04:00,IART,neutral
644107.0,Integra LifeSciences to Acquire TEI Biosciences and TEI Medical For $312M In Cash,2015-06-28 10:01:00-04:00,IART,neutral
644108.0,"Integra to Complete Tax-Free Spin-Off of SeaSpine on July 1, 2015",2015-06-09 08:32:00-04:00,IART,neutral
644109.0,Wells Fargo Upgrades Integra Lifesciences to Outperform,2015-05-01 06:44:00-04:00,IART,positive
644110.0,Wells Fargo Upgrades Integra Lifesciences to Outperform,2015-05-01 06:21:00-04:00,IART,positive
644111.0,"Integra LifeSciences Holdings Corporation Reports Q1 EPS Adj EPS $0.76 Vs Est $0.63, Sales $233.7M Vs Est $229.64M",2015-04-30 16:33:00-04:00,IART,neutral
644112.0,"Integra Lifesciences Q1 Adj. EPS $0.76 vs $0.63 Est., Sales $233.7M vs $229.6M Est.; Sees FY15 Adj. EPS $3.15-$3.33 vs $3.17 Est.",2015-04-30 16:23:00-04:00,IART,neutral
644113.0,8-K from Integra Lifesciences Shows Co. to Report in Three Segments in Q1'15,2015-04-13 16:33:00-04:00,IART,neutral
644114.0,"Piper Jaffray Initiates Coverage on Integra Lifesciences at Overweight, Announces $67.00 PT",2015-03-10 11:01:00-04:00,IART,negative
644115.0,UPDATE: Integra Lifesciences Slideshow Shows Company Repeats Revenue Forecast,2015-03-02 12:08:00-05:00,IART,neutral
644116.0,"Integra Lifesciences Offers Slideshow Presentation for Raymond James Institutional Investors Conference: Targeting Long-Term Adj. EPS Growth 10+%, Sales Growth 7+%",2015-03-02 12:05:00-05:00,IART,positive
644117.0,"Integra Lifesciences Q4 EPS $0.94 vs $0.89, Revenue $252.2M vs $244.2M",2015-02-24 06:02:00-05:00,IART,neutral
644118.0,Integra LifeSciences Announces Submission of a Premarket Approval Supplement Application for Integra Dermal Regeneration Template,2015-02-03 17:01:00-05:00,IART,positive
644119.0,"Integra LifeSciences Reports Resolution of Warning Letter Related to Plant in Anasco, Puerto Rico",2015-01-20 08:01:00-05:00,IART,negative
644120.0,Integra Announces Acquisition of Metasurg's Foot and Ankle Portfolio,2015-01-12 09:02:00-05:00,IART,neutral
644121.0,Integra LifeSciences Launches Integra Meshed Dermal Regeneration Template,2014-12-17 08:49:00-05:00,IART,neutral
644122.0,UPDATE: Integra LifeSciences Announces FDA Clearance And Controlled Market Release Of Expandable Interbody System For Spinal Surgery,2014-11-13 08:51:00-05:00,IART,neutral
644123.0,Integra LifeSciences Announces FDA Clearance And Controlled Market Release of Expandable Interbody System for Spinal Surgery,2014-11-13 08:40:00-05:00,IART,neutral
644124.0,Integra LifeSciences Introduces Integra(R) Pocket Strip and Integra(R) Shaped Strip DBM Implants,2014-11-12 08:36:00-05:00,IART,neutral
644125.0,Integra LifeSciences Introduces Integra Pocket Strip And Integra Shaped Strip DBM Implants,2014-11-12 08:31:00-05:00,IART,neutral
644126.0,Integra LifeSciences Shares to Resume Trade at 4:30 p.m. EST,2014-11-03 16:22:00-05:00,IART,positive
644127.0,Integra LifeSciences Holdings Corporation Reports Q3 EPS of $0.76 vs $0.74 Est; Revenue of $229.70M vs $233.47M Est.  Spinning Off One Unit To Be Called SEASPINE,2014-11-03 16:06:00-05:00,IART,neutral
644128.0,Integra LifeSciences Shares Halted News Pending,2014-11-03 16:04:00-05:00,IART,positive
644129.0,8-K from Integra Lifesciences Shows FDA Completed Anasco Inspection Following Warning Letter,2014-10-06 08:06:00-04:00,IART,negative
644130.0,Integra LifeSciences to Acquire Medtronic's MicroFrance and Xomed Manual ENT and Laparoscopy Instrumentation Lines for ~$60M,2014-09-17 06:20:00-04:00,IART,neutral
644131.0,"8-K from Integra Lifesciences Shows FDA is Inspecting Facility in Anasco, Puerto Rico, Began Probe on Sept. 4th",2014-09-08 16:21:00-04:00,IART,neutral
644132.0,Integra LifeSciences Announces Changes Within Its Orthopedics And Tissue Technologies Business,2014-09-02 08:01:00-04:00,IART,neutral
644133.0,"8-K from Integra Lifesciences Shows Two Former Sales Reps Plead Guilty, Charged with Improper Billing, Co. Says Was Not Target of State of NJ's Probe",2014-08-12 14:51:00-04:00,IART,negative
644134.0,Integra LifeSciences Reports Q2 Adjusted EPS of $0.68 vs $0.64 Est; Revenue of $231.40M vs $229.32M Est,2014-08-05 06:19:00-04:00,IART,neutral
644135.0,Integra LifeSciences Completes Multicenter Clinical Trial for Treatment of Diabetic Foot Ulcers ,2014-08-05 06:17:00-04:00,IART,neutral
644136.0,Integra LifeSciences Announces Renewal And Extension Of Credit Facility; Increased From $600M to $900M,2014-07-09 16:19:00-04:00,IART,positive
644137.0,Integra To Supply Small Bone Orthopedic Implants To Premier,2014-06-12 08:32:00-04:00,IART,neutral
644138.0,"Integra LifeSciences Appoints Coleman as CFO, Corporate VP",2014-04-29 16:21:00-04:00,IART,neutral
644139.0,"Integra LifeSciences Shares Flirting with Positive Territory After Lake Street Issued Mid-Day New Buy Rating, $55 Target",2014-04-23 11:52:00-04:00,IART,positive
644140.0,Integra Lifesciences Reports Camino Flex Ventricular Catheter Has Received FDA Clearance for Use with MRI,2014-04-04 08:36:00-04:00,IART,neutral
644141.0,"Integra LifeSciences Launches Integra(R) Wound Matrix (Thin), Says Has Received 510(k) Clearance from US, Expects to Begin Full Market Release in US in Apr. 2014",2014-03-25 08:36:00-04:00,IART,neutral
644142.0,Integra LifeSciences Receives FDA Clearance for Integra(R) Titanium Bone Wedges,2014-02-27 08:35:00-05:00,IART,neutral
644143.0,Morgan Stanley Sees Focus & Efficiency as Key for Integra Lifesciences,2014-02-26 10:15:00-05:00,IART,positive
644144.0,Integra LifeSciences Reports Q4 adjusted EPS of $0.78 vs $0.81 Est; Revenue of $220.80M vs $223.37M Est,2014-02-25 06:26:00-05:00,IART,neutral
644145.0,Bank of America Upgrades Integra LifeSciences Holdings Corporation to Neutral,2014-01-08 08:12:00-05:00,IART,neutral
644146.0,Top Stem Cells Stocks,2013-12-31 13:49:00-05:00,IART,positive
644147.0,Integra Lifesciences Reports FDA Closes Anaco Inspection,2013-12-03 08:04:00-05:00,IART,neutral
644148.0,UPDATE: Morgan Stanley Upgrades Integra LifeSciences Holdings Following Acquisition of Confluent Surgical,2013-11-11 09:39:00-05:00,IART,neutral
644149.0,"Morgan Stanley Upgrades Integra LifeSciences Holdings Corporation to Neutral, Removes $40.00 PT",2013-11-11 06:43:00-05:00,IART,neutral
644150.0,Integra LifeSciences Prices 3.5M Share Offering at $40.00/Share ,2013-11-06 21:54:00-05:00,IART,positive
644151.0,Integra LifeSciences Holdings Corporation Reports Q3 EPS of $0.72; Revenue of $213.20M,2013-10-28 16:06:00-04:00,IART,neutral
644152.0,UPDATE: Morgan Stanley Downgrades Integra Lifesciences Holdings Corp. as Cash Generation and 2014 Consensus EPS Are at Risk,2013-10-23 10:11:00-04:00,IART,negative
644153.0,"Morgan Stanley Downgrades Integra LifeSciences Holdings Corporation to Underweight, Announces $40.00 PT",2013-10-23 06:41:00-04:00,IART,neutral
644154.0,UPDATE: Integra Lifesciences Wins FDA 510(K) Clearance for C3-T3,2013-10-10 08:33:00-04:00,IART,positive
644155.0,Integra Lifesciences Wins FDA 510(K) Clearance for C3-T3,2013-10-10 08:32:00-04:00,IART,positive
644156.0,UPDATE: Integra Wins 510(K) Clearance for Hollywood Nanometalene IBD,2013-10-09 08:34:00-04:00,IART,positive
644157.0,Integra Wins 510(K) Clearance for Hollywood Nanometalene IBD,2013-10-09 08:31:00-04:00,IART,positive
644158.0,"Barclays Initiates Coverage on Integra LifeSciences Holdings Corporation at Equalweight, Announces $43.00 PT",2013-10-04 09:08:00-04:00,IART,neutral
644159.0,Barclays Initiates Coverage on Integra LifeSciences Holdings Corporation at Equalweight,2013-10-04 09:05:00-04:00,IART,neutral
644160.0,Integra LifeSciences Announces Podium Presentation of NeuraGen(R) Nerve Guide Multi-Center Clinical Trial at ASSH ,2013-10-02 08:33:00-04:00,IART,neutral
644161.0,"Integra LifeSciences Holdings Corporation Appoints Donald E. Morel, Jr., Ph.D. as a Director and Announces Retirement of Neal Moszkowski as a Director",2013-08-27 16:05:00-04:00,IART,neutral
644162.0,"Market Wrap For Thursday, August 15: Stocks Plunge Amid Fears Of Fed Tapering ",2013-08-15 18:31:00-04:00,IART,negative
644163.0,UPDATE: Piper Jaffray Upgrades Integra LifeSciences On FDA Inspection Results,2013-08-15 07:56:00-04:00,IART,neutral
644164.0,Benzinga's Top Upgrades,2013-08-15 07:34:00-04:00,IART,positive
644165.0,"Piper Jaffray Upgrades Integra LifeSciences Holdings Corporation to Overweight, Raises PT to $50.00",2013-08-15 06:23:00-04:00,IART,negative
644166.0,"Oppenheimer Maintains Outperform on Integra LifeSciences Holdings Corporation, Raises PT to $46.00",2013-08-02 08:38:00-04:00,IART,neutral
644167.0,Integra LifeSciences Holdings Corporation Reports Q2 Adjusted EPS of $0.60 vs $0.55 Est; Revenue of $205.50M vs $207.30M Est,2013-08-01 06:23:00-04:00,IART,neutral
644168.0,Integra LifeSciences Receives FDA Clearance for Titan(TM) Reverse Shoulder System,2013-07-31 08:33:00-04:00,IART,neutral
644169.0,Wells Fargo Initiates Coverage on Integra LifeSciences Holdings Corporation at Market Perform,2013-06-04 08:11:00-04:00,IART,positive
644170.0,Integra LifeSciences Holdings Corporation Sees FY2013 EPS $2.40-2.70 vs $2.72 Est; Sees Sales $840.0M-852.0M vs $855.70M Est,2013-05-02 07:27:00-04:00,IART,neutral
644171.0,Integra LifeSciences Holdings Corporation Reports Q1 EPS of $0.39 vs $0.45 Est; Revenue of $196.70M vs $197.87M Est,2013-05-02 06:14:00-04:00,IART,neutral
644172.0,Benzinga's Volume Losers ,2013-04-11 11:43:00-04:00,IART,negative
644173.0,UPDATE: Piper Jaffray Lowers PT on Integra Following Anasco Recall,2013-04-11 11:05:00-04:00,IART,negative
644174.0,"Piper Jaffray Maintains Neutral on Integra LifeSciences Holdings Corporation, Lowers PT to $41.00",2013-04-11 07:30:00-04:00,IART,negative
644175.0,Integra Lifesciences Shares Resume Trading Down ~7%,2013-04-10 16:45:00-04:00,IART,positive
644176.0,Integra LifeSciences Holdings Corporation Sees Q1 EPS $(0.30)-(0.08); Lowers Q1 Sales Guidance from $202.0M-205.0M to $194.0M-197.0M,2013-04-10 16:21:00-04:00,IART,negative
644177.0,"Integra LifeSciences Issues Voluntary Recall of Certain Products Manufactured in its Anasco, Puerto Rico Facility",2013-04-10 16:17:00-04:00,IART,positive
644178.0,Integra Lifesciences Halted News Pending,2013-04-10 16:13:00-04:00,IART,neutral
644179.0,"Integra Lifesciences Sees Long-Term Adj. EPS Growth 9-13%, Sales Growth 5-7%",2013-03-11 12:31:00-04:00,IART,positive
644180.0,"JP Morgan Maintains Neutral on Integra LifeSciences Holdings Corporation, Raises PT to $45.00",2013-02-28 12:01:00-05:00,IART,positive
644181.0,"Piper Jaffray Maintains Neutral on Integra LifeSciences Holdings Corporation, Raises PT to $46.00",2013-02-22 14:37:00-05:00,IART,neutral
644182.0,"UPDATE: Jefferies Reiterates Buy Rating, Raises PT on Integra Life-Sciences Holdings on Weak 4Q Results",2013-02-22 11:04:00-05:00,IART,negative
644183.0,"Jefferies Maintains Buy on Integra LifeSciences Holdings Corporation, Raises PT to $46.00",2013-02-22 07:51:00-05:00,IART,neutral
644184.0,Integra LifeSciences Holdings Corporation Reports Q4 EPS of $0.78 vs $0.77 Est; Revenue of $214.40M vs $215.91M Est,2013-02-21 06:17:00-05:00,IART,neutral
644185.0,Integra Lifesciences Wins Three-Year Contract with Premier Healthcare Alliance,2013-01-31 08:34:00-05:00,IART,positive
644186.0,Integra Lifesciences Wins CE Mark Certification for Flowable Wound Matrix,2013-01-18 08:31:00-05:00,IART,positive
644187.0,"Janney Capital Initiates Coverage on Integra LifeSciences Holdings Corporation at Buy, Announces $52.00 PT",2013-01-11 09:31:00-05:00,IART,neutral
644188.0,Integra Lifesciences Guides 5-Year Gross Margin 68-70%,2013-01-09 16:51:00-05:00,IART,negative
644189.0,"Integra Lifescience Ahead of JPMorgan Healthcare Conference: Sees Five-Year Core Sales Growth 5-7%, Adj. EPS Growth 9-13%",2013-01-09 16:47:00-05:00,IART,positive
644190.0,UPDATE: JP Morgan Maintains Integra LifeSciences at Neutral Following Model Update  ,2012-12-27 13:58:00-05:00,IART,positive
644191.0,Bank of America Downgrades Integra LifeSciences Holdings Corporation to Underperform,2012-12-18 09:38:00-05:00,IART,neutral
644192.0,"SunTrust Initiated Coverage on Integra LifeSciences Holdings at Neutral, Announced PT to $33",2012-11-16 10:08:00-05:00,IART,neutral
644193.0,Integra LifeSciences Receives Warning Letter from FDA,2012-11-13 06:16:00-05:00,IART,negative
644194.0,Integra LifeSciences Receives FDA Clearance for Expanded Indication for Spinal Device,2012-10-09 08:09:00-04:00,IART,neutral
644195.0,Stocks Hitting 52-Week Highs,2012-09-25 10:21:00-04:00,IART,neutral
644196.0,"UPDATE: Oppenheimer Holdings Reiterates Outperform Rating, Raises PT on Integra Lifesciences Holdings",2012-09-10 13:03:00-04:00,IART,neutral
644197.0,"Oppenheimer Maintains Integra LifeSciences Holdings at Outperform, Raises PT from $42 to $46",2012-09-10 06:59:00-04:00,IART,neutral
644198.0,"UPDATE: Piper Jaffray Reiterates Neutral Rating, Raises PT on Integra LifeSciences",2012-07-30 10:54:00-04:00,IART,neutral
644199.0,"Piper Jaffray Maintains Integra LifeSciences Holdings at Neutral, Raises PT from $40 to $41",2012-07-30 07:12:00-04:00,IART,neutral
644200.0,UPDATE: Jefferies Raises PT on Integra Life-Sciences Holdings from $40 to $43,2012-07-27 11:39:00-04:00,IART,neutral
644201.0,"Jefferies & Company Maintains Integra LifeSciences Holdings at Buy, Raises PT from $40 to $43",2012-07-27 06:30:00-04:00,IART,neutral
644202.0,UPDATE: Bank of America Raises PO to $40 on Integra Lifesciences,2012-06-27 10:01:00-04:00,IART,negative
644203.0,"Bank of America Maintains Integra LifeSciences Holdings at Neutral, Raises PO from $36 to $40",2012-06-27 06:33:00-04:00,IART,negative
644204.0,Integra LifeSciences Announces Contract With aap Implantate AG to Provide Stainless Headed Compression Screws for Mid and Hindfoot Reconstruction ,2012-06-21 06:27:00-04:00,IART,negative
644205.0,"Integra Lifesciences Borrowed $155M Under Credit Pact, Will Use Funds to Repay Notes",2012-06-04 16:09:00-04:00,IART,positive
644206.0,Integra Entered Amended Credit Pact,2012-05-14 09:17:00-04:00,IART,positive
644207.0,"JP Morgan Maintains Integra LifeSciences Holdings at Neutral, Raises PT from $34 to $39",2012-04-27 10:58:00-04:00,IART,positive
644208.0,"Jefferies & Company Maintains Integra LifeSciences Holdings at Buy, Raises PT from $37 to $40",2012-04-27 07:07:00-04:00,IART,neutral
644209.0,Integra LifeSciences Holdings Reports Q1 EPS $0.71 vs $0.61 Est; Revenues $196M vs $192.75M Est,2012-04-26 08:16:00-04:00,IART,neutral
644210.0,UPDATE: Bank of America Raises Integra Lifesciences' PO,2012-04-24 08:13:00-04:00,IART,negative
644211.0,"Bank of America Maintains Integra LifeSciences Holdings at Neutral, Raises PO from $26 to $36",2012-04-24 06:45:00-04:00,IART,negative
644212.0,Integra LifeSciences Announces Launch of New Jarit Take-Apart Laparoscopic Instruments ,2012-03-26 06:46:00-04:00,IART,neutral
644213.0,Top 4 NASDAQ Stocks In The Medical Instruments & Supplies Industry With The Highest Revenue,2012-03-26 04:53:00-04:00,IART,positive
644214.0,A Peek Into The Market Before The Trading Starts,2012-03-22 07:20:00-04:00,IART,neutral
644215.0,Integra LifeSciences Launches New Shoulder Arthroplasty Device in Italy and Sweden ,2012-03-22 06:38:00-04:00,IART,neutral
644216.0,"Barrington Research Reiterates Integra LifeSciences Outperform, $50 PT",2012-02-28 15:44:00-05:00,IART,neutral
644217.0,"Piper Jaffray Maintains Integra LifeSciences Holdings at Neutral, Lowers PT from $35 to $34",2012-02-24 08:18:00-05:00,IART,negative
644218.0,UPDATE: Citigroup Raises Target to $36 on Integra Lifesciences Holdings,2012-02-24 07:56:00-05:00,IART,neutral
644219.0,Integra LifeSciences Holdings Reports Q4 EPS $0.72 vs $0.63 Est; Revenues $203.5M vs $202.00M Est,2012-02-23 06:50:00-05:00,IART,neutral
644220.0,"JP Morgan Maintains Integra LifeSciences Holdings at Neutral, Lowers PT from $37 to $36",2012-02-22 12:40:00-05:00,IART,positive
644221.0,FDA Sends Medical-Device Firm Integra LifeSciences A Warning Letter,2012-02-07 09:43:00-05:00,IART,negative
644222.0,FDA Says Certain Integra Devices Adulterated; Methods Used in Manufacturing Not in Conformity with the Practice -Reuters ,2012-01-31 10:14:00-05:00,IART,positive
644223.0,FDA Sends Warnings Letter to Integra Lifesciences -Reuters ,2012-01-31 10:11:00-05:00,IART,negative
644224.0,Integra LifeSciences Holdings Trading 2.2% Higher on Heavy Volume; Currently at $24.95,2012-01-13 14:26:00-05:00,IART,neutral
644225.0,Argus Downgrades Integra LifeSciences to Hold,2012-01-09 08:35:00-05:00,IART,neutral
644226.0,Integra LifeSciences Holdings Resumes Trading,2012-01-05 17:00:00-05:00,IART,neutral
644227.0,PREVIEW: Integra LifeSciences Holdings to Resume Trading at 5:00pm,2012-01-05 16:37:00-05:00,IART,neutral
644228.0,UPDATE: Integra Lifesciences Says Received FDA Warning Letter on Plainsboro Facility Inspection,2012-01-05 16:33:00-05:00,IART,negative
644229.0,Integra Lifesciences Guides Q4 Prelim EPS $0.65-0.70 vs $0.79 Est; Sees 2012 Revenues Rising 8%,2012-01-05 16:33:00-05:00,IART,neutral
644230.0,Trading Halted in Integra Lifesciences,2012-01-05 16:30:00-05:00,IART,neutral
644231.0,Benzinga's Top Downgrades,2011-12-23 08:58:00-05:00,IART,positive
644232.0,UPDATE: Disclosure Insight Downgrades Integra Lifesciences to Medium Risk - Negative Bias ,2011-12-23 07:23:00-05:00,IART,negative
644233.0,"Piper Jaffray Reiterates Neutral, $38 PT on Integra LifeSciences",2011-12-22 07:21:00-05:00,IART,neutral
644234.0,Jefferies Provides Color On Integra LifeSciences Holdings,2011-12-21 16:29:00-05:00,IART,neutral
644235.0,Integra LifeSciences Announces Appointment of Peter Arduini as President and Chief Executive Office,2011-12-21 09:01:00-05:00,IART,neutral
644236.0,"Integra LifeSciences Establishes First Office in Shanghai, China  ",2011-12-05 07:25:00-05:00,IART,neutral
644237.0,"Jefferies Maintains Buy, $43 PT on Integra LifeSciences  ",2011-11-15 08:33:00-05:00,IART,neutral
644238.0,JP Morgan Maintains Neutral Rating and $37 PT on Integra Lifesciences ,2011-11-15 08:04:00-05:00,IART,positive
644239.0,Morgan Stanley Equal-Weight on Integra LifeSciences,2011-11-15 07:46:00-05:00,IART,neutral
644240.0,UPDATE: JP Morgan Lowers PT on Integra LifeSciences to $37,2011-11-08 08:30:00-05:00,IART,positive
644241.0,"Financial Breakfast: Morning News Summary for November 8, 2011",2011-11-08 07:44:00-05:00,IART,neutral
644242.0,JP Morgan Lowers PT on Integra LifeSciences to $37,2011-11-08 06:17:00-05:00,IART,positive
644243.0,Barrington Maintains Outperform Rating on Integra LifeSciences after 3Q Revenue Beat,2011-11-01 10:31:00-04:00,IART,neutral
644244.0,UPDATE: Bank of America Merrill Lynch Lowers PT on Integra Lifesciences to $35,2011-11-01 09:42:00-04:00,IART,negative
644245.0,UPDATE: Oppenheimer Lowers PT on Integra LifeSciences Holdings to $43,2011-11-01 09:36:00-04:00,IART,negative
644246.0,Morgan Stanley Equalweight on Integra LifeSciences,2011-11-01 08:15:00-04:00,IART,neutral
644247.0,Oppenheimer Lowers PT on Integra LifeSciences to $43,2011-11-01 07:49:00-04:00,IART,negative
644248.0,Bank of America Lowers PO on Integra Lifesciences to $35,2011-11-01 07:43:00-04:00,IART,negative
644249.0,"End-of-Day Market Summary for October 31, 2011",2011-10-31 16:16:00-04:00,IART,neutral
644250.0,Top Movers; Sify Technologies up 30%,2011-10-31 15:58:00-04:00,IART,positive
644251.0,"Integra LifeSciences Hits New 52-Week Low, $31.65",2011-10-31 15:45:00-04:00,IART,negative
644252.0,Citi Maintains Buy Rating and $42 PT on Integra Lifesciences Holdings ,2011-10-31 10:31:00-04:00,IART,neutral
644253.0,From Earlier: Integra LifeSciences Reports Q3 EPS $0.77 vs $0.77 Est; Revenues $202.19M vs $204.15M Est		,2011-10-31 07:13:00-04:00,IART,neutral
644254.0,"Citigroup Upgrades Integra LifeSciences to Buy, PT Lowered to $42",2011-10-06 05:53:00-04:00,IART,negative
644255.0,Integra LifeSciences Announces Agreement to Acquire Ascension Orthopedics For $65M,2011-09-12 09:16:00-04:00,IART,positive
644256.0,Integra LifeSciences Announces Multi-Year Agreement With Premier Purchasing Partners to Provide Neurosurgical Products ,2011-09-01 06:45:00-04:00,IART,positive
644257.0,RTI Biologics and STAAR Surgical End the Week Near 52-Week Highs,2011-08-20 11:37:00-04:00,IART,neutral
644258.0,UPDATE: Stifel Nicolaus Initiates Integra LifeSciences Holdings at Hold,2011-08-18 09:13:00-04:00,IART,neutral
644259.0,"Jefferies Reiterates Buy on Integra LifeSciences, Slashes PT to $55",2011-07-29 08:17:00-04:00,IART,negative
644260.0,Morgan Stanley Comments on Mergers and Acquisitions at Integra Lifesciences,2011-07-29 07:01:00-04:00,IART,neutral
644261.0,Jefferies Lowers PT on Integra Life-Sciences To $55,2011-07-29 06:58:00-04:00,IART,negative
644262.0,Integra Reports Q2 EPS $0.70 vs $0.69 Est; Revenues $193.3M vs $188.88M Est ,2011-07-28 08:43:00-04:00,IART,neutral
644263.0,"Bank of America Initiates Integra Lifesciences At Neutral, $50 PT",2011-07-08 08:40:00-04:00,IART,neutral
644264.0,Piper Jaffray Neutral On Integra LifeSciences,2011-06-22 08:12:00-04:00,IART,neutral
644265.0,Citi Reiterates Hold on Integra Lifesciences Holdings,2011-06-14 07:43:00-04:00,IART,neutral
644266.0,Integra Announces Pricing of Convertible Senior Notes at Approx. $57.44/Share,2011-06-10 07:30:00-04:00,IART,neutral
644267.0,Integra Announces Private Placement of Convertible Senior Notes,2011-06-09 07:11:00-04:00,IART,neutral
644268.0,Jefferies Comments on Integra Life-Sciences Acquisition,2011-05-25 07:49:00-04:00,IART,neutral
644269.0,Integra LifeSciences Announces Three-Year Contract With Novation to Provide Luxtec Surgical Headlights (IART),2011-05-04 07:09:00-04:00,IART,neutral
644270.0,Stem Cell Funding Band Reversed: What About the Stocks?,2011-05-01 18:14:00-04:00,IART,neutral
644271.0,Integra LifeSciences Reports EPS of $0.38 vs. $0.66 Estimate; Revenues $181M vs. $180.84M Estimate (IART),2011-04-28 08:54:00-04:00,IART,neutral
644272.0,Integra LifeSciences Announces FDA Clearance for New Indication for Accell Evo3 Demineralized Bone Matrix ,2011-04-12 07:25:00-04:00,IART,neutral
644273.0,Oppenheimer Surveys Non-Profit Hospitals' 1Q11,2011-04-06 07:25:00-04:00,IART,neutral
644274.0,Stem Cell Stocks Are Growing,2011-03-12 00:22:00-05:00,IART,positive
644275.0,Piper Jaffray Comments On Integra LifeSciences Following Earnings,2011-02-25 07:37:00-05:00,IART,neutral
644276.0,Piper Jaffray Raises PT On Integra LifeSciences To $177,2011-02-25 07:11:00-05:00,IART,neutral
644277.0,Integra LifeSciences Reports Better-Than-Expected Q4 Earnings,2011-02-24 06:52:00-05:00,IART,neutral
644278.0,J.P. Morgan Raises IART Target To $53; Lowers Rating To Neutral,2011-01-03 12:16:00-05:00,IART,negative
644279.0,JP Morgan Downgrades Integra LifeSciences To Neutral,2011-01-03 07:03:00-05:00,IART,positive
644280.0,Jefferies Initiates Integra Life-Sciences At Buy,2010-12-03 08:34:00-05:00,IART,neutral
644281.0,Jefferies Initiates Coverage on Integra Life-Sciences (IART),2010-12-03 07:45:00-05:00,IART,neutral
644282.0,Jefferies Initiates IART At Buy,2010-12-03 07:02:00-05:00,IART,neutral
644283.0,Piper Jaffray Has $48 Target On Integra LifeSciences  (IART),2010-12-01 07:30:00-05:00,IART,neutral
644284.0,Madison Williams Initiates IART With Buy,2010-11-30 07:47:00-05:00,IART,neutral
644285.0,"Integra Lifesciences M&A Unlikely Until 2011, Citigroup Reports",2010-11-12 07:36:00-05:00,IART,neutral
644286.0,"Integra Beats, Ups EPS Guidance - Analyst Blog",2010-10-29 13:51:00-04:00,IART,neutral
644287.0,First US Trial of Embryonic Stem Cells in Humans,2010-10-11 15:20:00-04:00,IART,neutral
644288.0,Morgan Stanley's Equity Morning Summary,2010-09-10 09:30:00-04:00,IART,neutral
644289.0,Oppenheimer Initiates Integra LifeSciences With $44 Target (IART),2010-09-07 18:07:00-04:00,IART,neutral
644290.0,Integra Recalls Brain Catheters - Analyst Blog,2010-08-25 18:00:00-04:00,IART,neutral
644291.0,Integra Adds iPASSAGE Retractor  - Analyst Blog,2010-08-16 16:35:00-04:00,IART,neutral
644292.0,Integra Inks deal with Amerinet  - Analyst Blog,2010-08-13 16:22:00-04:00,IART,neutral
644293.0,"Integra Beats, Reaffirms Guidance - Analyst Blog",2010-07-30 15:40:00-04:00,IART,neutral
644294.0,Top Stem Cell Stocks,2010-07-25 16:45:00-04:00,IART,positive
644295.0,Piper Jaffray Maintains Neutral Rating And Price Target On Integra LifeSciences (IART),2010-05-06 12:33:00-04:00,IART,neutral
644296.0,Integra LifeSciences (IART) Reports A 59% Increase In Its First-Quarter Profit,2010-05-03 08:19:00-04:00,IART,positive
644297.0,"Benzingaâs Volume Movers (PFWD, MDSO, IART, INTC, GPRE)",2010-04-16 15:23:00-04:00,IART,neutral
644298.0,"Benzingaâs Volume Movers (BARE, MAPP, HWCC, LEAP, IART)",2010-01-15 14:30:00-05:00,IART,neutral
644299.0,"Benzingaâs Volume Movers (HMIN, ASEI, OSIS, CAGC, IART)",2010-01-04 14:12:00-05:00,IART,neutral
